Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/27/23
End: 08/31/24
Due: 08/31/25
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 12/01/21
End: 05/09/23
Due: 05/09/24
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 03/31/13
Due: 03/31/14
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| MSP3-CRM-Vac4All/ Alhydrogel® Vaccine | NCT05776017 | Vac4All | user2@example.com | None | 2023-03-27 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |
| Trial for Malaria Vaccine Candidate, PfPEBS (P. Falciparum Pre-Erythrocytic and Blood Stage) | NCT01605786 | Vac4All | user2@example.com | None | 2012-05-31 | 2013-08-31 | 2014-08-31 | - | - | 2025-07-14 |
| MSP3-CRM-Vac4All/ Alhydrogel® Malaria Vaccine | NCT05197751 | Vac4All | user2@example.com | None | 2021-12-01 | 2023-05-09 | 2024-05-09 | - | - | 2025-07-14 |
| Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in Africa | NCT01341704 | Vac4All | user2@example.com | None | 2011-05-31 | 2013-03-31 | 2014-03-31 | - | - | 2025-07-14 |